SILENCE THERAPEUTICS PLC ORDINARY SHARES (OTCMKTS:SLNCF) Has Decline in ShortsMarch 12, 2018 - By Peter EricksonThe stock of SILENCE THERAPEUTICS PLC ORDINARY SHARES (OTCMKTS:SLNCF) registered a decrease of 12.5% in short interest. Silence Therapeutics plc (OTCMKTS:SLNCF) has 0.00% since March 12, 2017 and is . Silence Therapeutics plc focuses on the discovery, development, and delivery of RNA therapeutics. More recent Silence Therapeutics plc (OTCMKTS:SLNCF) news were published by: Ft.com which released: “Private investors stake their dreams on risky biotech start-ups” on April 19, 2015. Huffingtonpost.com‘s news article titled: “Why Silence Is So Good For Your Brain” with publication date: March 05, 2016 was also an interesting one.

Source: Huffington Post March 12, 2018 13:18 UTC